How Do You Prescribe for Patients with Beta-Lactam Allergies Without a Skin Test or Allergy Consult?
Christopher McCoy, PharmD, shares the protocol for approaching patients who may have a beta-lactam allergy.
Watch
Multicenter Stewardship Initiative Reduces Antibiotic Use for Community-Acquired Pneumonia
Prolonged antibiotic use opens the door to the development of antibiotic resistance, superinfections, and the risk of Clostridium difficile infections.
Read More
Nearly 10% of Americans with Candidemia have Clostridium difficile Co-infection
The message for clinicians is to be vigilant. Look for candidemia and C. difficile infection occurring together.
What Advantage Does Delafoxacin Have Over Other Fluoroquinolones?
Sue Cammarata, MD, explains the advantages that delafloxcin has over other fluoroquinolones.
The Use of Combination Antifungal Therapy is Not a Black and White Issue
Using combination antifungal therapy for invasive mold diseases is still a grey area that remains to be supported by robust data and relies heavily on clinician assessment.
ID Week 2017 Closing Plenary Provides Guarded Optimism for Coming Decades
Thoughts leaders believe infectious disease treatment is in the middle of a sea change, moving from antibiotics to antibodies.
What Is the Standardized Antimicrobial Administration Ratio?
Neil Fishman, MD, explains what the standardized antimicrobial administration ratio is.
Antibiotic Therapy for Staphylococcal Bloodstream Infections: Doing the Same with Less
Researchers found that the use of the treatment algorithm for staphylococcal bacteremia shortens therapy without compromising outcomes.
All Antibiotic Orders Should Include Indication for Use
Emily Heil, PharmD, BCPS-AQ ID, sheds light on one of the standards of new antibiotic stewardship regulations: all antibiotic orders should include indication for use.
The Promise and Peril of Second-Generation Beta-Lactam Inhibitor Combinations
Whether the oft-repeated pattern of initial drug success followed by increasing resistance plays out in the future for many drugs remains to be seen.
CD101: A New Long-Acting Echinocandin
David Andes, MD, shares the half-life and dosing intervals for a new long-acting echinocandin.
Ribaxamase Found to Prevent New Onset Clostridium difficile Infections
About 500,000 Americans fall ill from Clostridium difficile infections every year.
Antibiotics Prescribed by Dentists May Be Contributing to CDI Incidence
Dr. Maria Bye, an epidemiologist at the Minnesota Department of Health shares some unsettling news when it comes to C. difficile: dentists’ prescribing habits may be contributing to CDI incidence.
What Are the Results of the REVIVE-2 Trial?
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Addressing the Growing Problem of Resistant Fungi
Candidemia is the most common healthcare-associated bloodstream infection in the United States, with an incidence of 5-15 per 100,000 persons.
What Makes Eravacycline a Unique Antibiotic?
Patrick Horn, MD, PhD, explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.
Preparing for Pandemics and Streamlining Vaccine Development
It is only a matter of time before the next infectious disease pandemic hits and healthcare officials need to be prepared.
San Diego Health Officials Respond to "Surprising Return" of Hepatitis A
Dr. Monique Foster, CDC, and Dr. Eric McDonald, San Diego County Health and Human Services Agency, discuss the surprising return of hepatitis A virus as part of the Late Breakers I symposium.
Addressing Issues Surrounding Current Antibiotic Development
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
How Does Zika Virus Cause Auditory Loss?
Viviane Boaventura, MD, MsC, PhD, explains how Zika virus causes auditory loss.
Using Neural Networks to Predict Multidrug-resistant Organisms
Alan Gross, PharmD, explains how a neural network can help identify patients who are at increased risk for multidrug-resistant pathogens.
Hospital Epidemiologists Should Continually Tailor Bundles to Ensure Effectiveness
Silvia Munoz-Price, MD, PhD, explains why infection control bundles should evolve as the problems faced by hospital epidemiologists continue to change.
Long-Acting Injectable: An Exciting New Option for HIV Prevention
Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Contagion® to Report on ID Week 2017 in San Diego
Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.
First Peer-Reviewed Journal Largely Devoted to Zika Virus Research
David A. Schwartz, MD, MS Hyg, FCAP, explains how researchers from all over the world have come together to share their research on Zika virus.
How Prevalent is Lyme Disease in Israel?
Silvio Pitlik, MD, provides insight into the prevalence of Lyme disease in Israel.
Issues Faced by Lyme Disease Patients Living in Europe
Prof. Francisco Veas, PhD, chief security officer, Institut de Recherche pour le Développement, France, explains some of the issues faced by patients with Lyme disease living in Europe.
Challenges Faced When Creating a Vaccine for HIV
Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.
What Were the Results of the Phase 3 EMERALD Trial?
Magda Opsomer, MD, shares the results of the Phase 3 EMERALD trial for darunavir.
How Can Decision Makers Use the Population-based HIV Impact Assessment Project Data?
Jessica Justman, MD, explains how decision makers can use the Population-based HIV Impact Assessment Project data.
